Assenagon Asset Management
VYGR icon

Assenagon Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Assenagon Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,381
Closed -$64.4K – 1224
2025
Q4 		$64.4K Buy
+16,381
New +$72.5K ﹤0.01% 1138
2024
Q2 		– Sell
-28,896
Closed -$269K – 1500
2024
Q1 		$269K Buy
28,896
+10,936
+61% +$92.3K ﹤0.01% 1305
2023
Q4 		$152K Sell
17,960
-16,199
-47% -$118K ﹤0.01% 1378
2023
Q3 		$265K Sell
34,159
-165,333
-83% -$1.51M ﹤0.01% 1307
2023
Q2 		$2.28M Buy
199,492
+86,327
+76% +$893K 0.01% 728
2023
Q1 		$873K Buy
+113,165
New +$900K ﹤0.01% 1094
2022
Q4 		– Sell
-16,224
Closed -$96K – 1460
2022
Q3 		$96K Sell
16,224
-3,517
-18% -$22.5K ﹤0.01% 1297
2022
Q2 		$117K Buy
+19,741
New +$133K ﹤0.01% 1404
2021
Q4 		– Sell
-52,547
Closed -$138K – 1572
2021
Q3 		$138K Sell
52,547
-41,580
-44% -$135K ﹤0.01% 1252
2021
Q2 		$389K Sell
94,127
-185,946
-66% -$843K ﹤0.01% 1071
2021
Q1 		$1.32M Buy
280,073
+63,914
+30% +$436K 0.01% 832
2020
Q4 		$1.55M Buy
216,159
+75,757
+54% +$728K 0.01% 586
2020
Q3 		$1.5M Buy
+140,402
New +$1.65M 0.01% 658

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management's VYGR Position: Q1 2026 in Review

Assenagon Asset Management sold out of Voyager Therapeutics (VYGR) in Q1 2026, closing a stake of 16,381 shares — an estimated $64.4K sold.

Assenagon Asset Management first reported a position in VYGR in Q3 2020 and held it in 13 quarters. The position peaked at $2.28M in Q2 2023. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Assenagon Asset Management reported no remaining Voyager Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 16,381 Voyager Therapeutics shares in Q1 2026, an estimated $64.4K.
  • Assenagon Asset Management first reported a position in Voyager Therapeutics in Q3 2020 and held it in 13 quarters.
  • Assenagon Asset Management's Voyager Therapeutics position peaked at $2.28M in Q2 2023.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.